Article
Enhanced splicing modulation by NMA-modified antisense oligonucleotides
2025-10-07
Abstract excerpt
Aberrant RNA splicing contributes to many human diseases, and splice‑switching antisense oligonucleotides (SSOs) are ideally suited as a therapeutic strategy to modulate splicing and restore normal gene expression. Nusinersen (Spinraza™) has revolutionized the treatment of spinal muscular atrophy. It is a splice-switching oligonucleotide (SSO) that is modified with 2′- O -methoxyethyl (MOE) modifications. Here, w...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0bba2a8f-c0e9-596b-8776-6d480664fe8f
- DOI
- 10.1101/2025.10.06.680653
